Donor Supply: The Real Limit On Any Hair Transplant

A first consultation about hair restoration surgery usually opens with a number. How many grafts will I need? The more useful question runs in the opposite direction, and very few people arrive having asked it: how many grafts do you actually have available to spend, across the whole of your life?

Every follicle placed into a thinning area has to be taken from somewhere else on the same head. That somewhere is finite, it does not regenerate, and it sets the ceiling on what surgery can ever achieve. Anyone weighing up hair transplant surgery in Singapore is really being asked to plan around that ceiling, whether or not the conversation is framed that way.

Surgery redistributes hair, it does not create it

Hair restoration surgery moves follicular units from the back and sides of the scalp into areas that have thinned. Relocated follicles keep the characteristics of the region they came from, which is why they continue to grow in their new position. Nothing about the procedure increases the total number of follicles on your head.

Available donor hair has been described as the rate-limiting step in hair transplantation, with the surgical task being to harvest enough to address the balding pattern without depleting the donor area in the process¹. That single constraint explains most of what follows.

What donor density actually measures

Donor density is counted as follicular units per square centimetre. A follicular unit is a natural grouping of one to four hairs emerging from the scalp together, so the number of units and the number of individual hairs are different figures. In the mid-occipital scalp, follicular unit density typically runs between 65 and 85 units per square centimetre, with hair density roughly two and a half to three times that¹.

Those figures are not universal. Morphometric work on Chinese scalps recorded 71.78 follicular units and 137.08 hairs per square centimetre, averaging 1.91 hairs per unit, with two-hair units the most common group². Measured against Caucasian scalps, the same study put Chinese donor areas at roughly 0.72 follicular units per square millimetre against 1.0².

For a Singapore readership that gap deserves attention, since much of the graft-count guidance circulating online is built on Western density figures. Starting with a smaller donor bank changes what a realistic plan looks like.

The safe donor zone is a judgement, not a boundary

The region considered permanently safe to harvest sits in a band across the back and sides, where follicles are largely insensitive to the hormonal process driving pattern loss. Its size varies enormously between individuals. A study of 1,008 Korean men measuring the position of the parietal whorl found the distance from the whorl to the occipital fringe ranged from 0.5 to 5.5 centimetres, and the authors stated plainly that no known factor scientifically predicts the rate of alopecia progression or marks out a permanently safe donor area in advance³. Their data indicated that loss mostly progresses within six centimetres of the whorl towards the occiput³. A zone drawn generously in a man of thirty can sit inside the balding area twenty years later.

The floor you cannot harvest below

Extraction thins the donor area permanently. A multicentre study of 119 Chinese men with androgenetic alopecia recorded a baseline safe donor area of 76.82 follicular units per square centimetre and concluded that density should be left at no less than 60 units per square centimetre once harvesting is complete⁴. In practice that allows roughly a fifth of the donor follicular units to be removed before the area itself begins to look sparse.

The same arithmetic explains why transplanted density is deliberately set below native density. Hairline reconstruction in the Chinese morphometric series was performed at around 30 follicular units per square centimetre, approximately 40 per cent of natural density, and still read as a natural hairline². Coverage is an optical effect as much as a numerical one.

Progression is the harder variable

Androgenetic alopecia keeps recruiting new territory over decades. A community study across six Chinese cities, with 15,257 completed questionnaires, found prevalence among men rising from 2.8 per cent between the ages of 18 and 29 to 13.3 per cent in the thirties, 21.4 per cent in the forties and 41.4 per cent at seventy and above⁵. A man in his early thirties has usually not finished losing hair.

Surgery does not alter that process. A plan built only around today’s pattern can leave transplanted hair standing in front of an area that thins later, which is why surgeons are cautious about operating on men in their early twenties, when the eventual pattern cannot yet be read¹.

When surgery is not the right answer

Not everyone is a suitable candidate, and the donor area is usually what decides it. Diffuse unpatterned alopecia, in which thinning affects the donor region itself instead of sparing it, makes for a poor surgical result. Low follicular unit density in the region of 40 to 50 units per square centimetre, or donor miniaturisation above 20 per cent, are both negative factors which may count against proceeding¹. An assessment that recommends against surgery is doing its job.

Medical therapy protects what surgery cannot

Transplanted follicles resist the process. The native hair around them does not. A randomised, double-blind, placebo-controlled trial of 79 men aged 20 to 45 undergoing transplantation found that participants taking finasteride showed significantly greater improvement than placebo on both expert photographic assessment and macrophotographic hair counts at 48 weeks⁶. The authors framed the underlying problem precisely: surgical coverage can be diminished by continued miniaturisation and loss of pre-existing, non-transplanted hairs⁶.

Minoxidil vs finasteride is a comparison many patients have already worked through before surgery is on the table, and the two questions are not separable. Whether any medicine suits you, and which one, is a decision for assessment by a doctor and not something to settle from a website. Pooled figures for graft survival in men with androgenetic alopecia have been reported in the region of 85 to 93 per cent¹, though that is a range drawn from the literature and not a result any individual can be promised.

Conclusion

Donor supply is the quiet constraint sitting behind every decision in hair restoration, and a plan that respects it tends to age more gracefully than one built to maximise coverage in a single sitting. At Angeline Yong Dermatology, Dr Angeline Yong assesses donor characteristics, the pattern of loss and its likely progression before discussing whether surgery is appropriate at all, along with the medical treatment that would need to run alongside it. Book a consultation to talk through what your own donor area allows.

References

Jimenez, F., Alam, M., Vogel, J. E., & Avram, M. R. (2021). Hair transplantation: Basic overview. Journal of the American Academy of Dermatology, 85(4), 803-814. https://doi.org/10.1016/j.jaad.2021.03.124

Tsai, R.-Y., Lee, S.-H., & Chan, H.-L. (2002). The distribution of follicular units in the Chinese scalp: Implications for reconstruction of natural-appearing hairlines in Orientals. Dermatologic Surgery, 28(6), 500-503. https://doi.org/10.1046/j.1524-4725.2002.01194.x

Park, J. H., Na, Y. C., Moh, J. S., Lee, S. Y., & You, S. H. (2014). Predicting the permanent safe donor area for hair transplantation in Koreans with male pattern baldness according to the position of the parietal whorl. Archives of Plastic Surgery, 41(3), 277-284. 10.5999/aps.2014.41.3.277

Sun, B., Zhang, S., Pradhan, S., Zhao, W., Xu, Y., Zhang, X., Diao, Y., & Jiang, X. (2020). Investigation of optimum transplant and extraction density based on the data from the donor area of Chinese androgenetic alopecia patients: A multicenter, retrospective study. Journal of Cosmetic and Laser Therapy, 22(3), 137-140. https://doi.org/10.1080/14764172.2020.1761550

Wang, T. L., Zhou, C., Shen, Y. W., Wang, X. Y., Ding, X. L., Tian, S., Liu, Y., Peng, G. H., Xue, S. Q., Zhou, J. E., Wang, R. L., Meng, X. M., Pei, G. D., Bai, Y. H., Liu, Q., Li, H., & Zhang, J. Z. (2010). Prevalence of androgenetic alopecia in China: A community-based study in six cities. British Journal of Dermatology, 162(4), 843-847. https://doi.org/10.1111/j.1365-2133.2010.09640.x

Leavitt, M., Perez-Meza, D., Rao, N. A., Barusco, M. N., Kaufman, K. D., & Ziering, C. (2005). Effects of finasteride (1 mg) on hair transplant. Dermatologic Surgery, 31(10), 1268-1276. https://doi.org/10.1111/j.1524-4725.2005.31202

Use of this website signifies your agreement to The Terms of Use & Privacy Policy

Terms of Use

You are deemed to have entered into an agreement with Angeline Yong Dermatology and to have agreed to be bound by the terms set out below by accessing ayd.com.sg (“the Sites”) or by otherwise accessing any content found on this web site. By accessing or using the Site, you acknowledge that you have read, understood, and agreed, without limitation or qualification, to be bound by these Terms & Conditions. The Site is owned and operated by Angeline Yong Dermatology.

Intellectual Property Protection
Use of Angeline Yong Dermatology Content
Changes to the Site
Privacy Policy
No Warranty, Disclaimer of Liability and Indemnity
Force Majeure
Miscellaneous
Governing Law and Jurisdiction

Intellectual Property Protection

The contents and design of the Site and any material e-mailed to you or otherwise supplied to you in conjunction with the Site (such contents, design and materials being collectively referred to as the “Angeline Yong Dermatology Content”, are copyright of Angeline Yong Dermatology. You may not use or reproduce or allow anyone to use or reproduce any trademarks (such as ” Angeline Yong Dermatology” name and logo or other trade names appearing on the Site) for any reason without written permission from Angeline Yong Dermatology. The software, which operates the Site, is proprietary software and you may not use it except as expressly allowed under these Terms. You may not copy, modify, reverse engineer or otherwise interfere with the software.

Use of Angeline Yong Dermatology Content

You may retrieve and display the Angeline Yong Dermatology Content on a computer screen or mobile telephone, print individual pages on paper (but not photocopy them) and store such pages in electronic form for your personal, non-commercial use. You may not save or post any of the Content on blogs, Facebook, and other websites that allows viewing by the general public without written permission from Angeline Yong Dermatology. Except as expressly set out above, you may not reproduce, modify or in any way commercially exploit any of the Angeline Yong Dermatology Content.

Changes to the Site

Angeline Yong Dermatology reserves the right to change, modify, suspend, add or remove portions of the Angeline Yong Dermatology Content available on the Site at any time and to restrict the use and accessibility of the Site in its discretion and without prior notification.

Privacy Policy

The information that you provide about yourself and your company to Angeline Yong Dermatology will only be used in accordance with Angeline Yong Dermatology’s Privacy Policy Statement. We will:

retain your information only for as long as there is a business need
take reasonable steps to ensure that the information is accurate, adequate, relevant and up to date.
update or correct your information held by us whenever necessary
take appropriate measures to prevent and minimize risks of unauthorised access to the information

We may use your personal information, such as your name and contact details, for the following purposes:

to perform the services that you have requested, which may involve contacting you by telephone, mobile phone, fax machine, post or email, including sending you electronic direct mailers.
to allow us to promote our products, events and activities.

No Warranty, Disclaimer of Liability and Indemnity

Whilst every effort has been made to ensure the high quality and accuracy of the Site, Angeline Yong Dermatology makes no warranty, express or implied, concerning the Angeline Yong Dermatology Content, the Site, software or products or services available through the Site (the “Site Services”), which are provided “as is”. Angeline Yong Dermatology expressly disclaims all warranties, including but not limited to warranties of fitness for a particular purpose and warranties of merchantability. In no event will Angeline Yong Dermatology, its affiliates or other suppliers be liable for direct, special, incidental, or consequential damages (including, without limitation, damages for loss of business profits, business interruption, loss of business information or other pecuniary loss) arising directly or indirectly from the use of (or failure to use) or reliance on the Site Services, even if Angeline Yong Dermatology and its affiliates has been advised of the possibility that such damages may arise.

Angeline Yong Dermatology does not guarantee the accuracy, content, or timeliness of the Site Services or that they or related systems are free from viruses or other contaminating or destructive properties. Angeline Yong Dermatology accepts no responsibility for the content on any site to which a hypertext link from this site exists. The links are provided “as is” with no warranty, express or implied for the information provided within them.

Upon accessing to this Site, you agree to indemnify and hold harmless Angeline Yong Dermatology and its affiliates from any claims and expenses, including reasonable legal fees, related to any breach of these Terms by you or your use of any Site Services.

Force Majeure

Angeline Yong Dermatology and its affiliates will not be liable or deemed to be in default for any delay or failure in performance or interruption of the delivery of the Angeline Yong Dermatology Content resulting directly or indirectly from any cause or circumstance beyond its or their reasonable control, including but not limited to failure of electronic or mechanical equipment or communication lines, telephone or other interconnect problems, computer viruses, unauthorized access, theft, operator errors, severe weather, earthquakes or natural disasters, strikes or other labour problems, wars, or government restrictions.

Miscellaneous

Changes to these Terms. Angeline Yong Dermatology may, in its discretion, change these Terms (including those relating to your use of Site and/or the Angeline Yong Dermatology Content. When Terms are changed, Angeline Yong Dermatology will notify you by email or by publishing details of those changes by including them in these Terms. If you use the Site after Angeline Yong Dermatology has published or notified you of the changes, you are agreeing now to be bound by those changes. If you do not agree to be bound by those changes, you should not use the Site any further after they are published. Access to certain areas of the Angeline Yong Dermatology Content may be subject to additional terms and conditions.

Advertising, Third Party Content and other Web Sites. Parts of the Site may contain advertising or other third-party content. Advertisers and other content providers are responsible for ensuring that material submitted for inclusion on the Site complies with international and national law. Angeline Yong Dermatology is not responsible for any third-party content or error, omission or inaccuracy in any advertising material. The Site may contain links to other web sites. Angeline Yong Dermatology is not responsible for the availability of these web sites or their contents.

Assignment of Agreement. This agreement is personal to you and your rights and obligations under these Terms may not be assigned, sub-licensed or otherwise transferred. This agreement may be assigned to a third party by Angeline Yong Dermatology and its affiliates.

Non-Waiver. No delay or omission on the part of either party in requiring performance by the other party of its obligations will operate as a waiver of any right.

Notices. Notices to Angeline Yong Dermatology and its affiliates must be given in writing by letter.

Severability/Survival/Statute of Limitations. If any provision of these Terms is invalid or unenforceable, such will not render all the Terms unenforceable or invalid but rather the Terms will be read and construed as if the invalid or unenforceable provision(s) are not contained therein. Any cause of action of yours with respect to these Terms must be filed in a court of competent jurisdiction in Singapore, within one year after the cause of action has arisen, or such cause will be barred, invalid, and void.

Whole Agreement. Save as expressly referred to herein, any representation, warranty, term or condition not expressly set out in these Terms shall not apply.

Headings. Headings in these Terms are for convenience only and have no legal meaning or effect.

Governing Law and Jurisdiction

These Terms shall be governed by, and construed in accordance with the Laws of the Republic of Singapore. The parties irrevocably agree that the courts of Singapore shall (subject to the paragraph below) have exclusive jurisdiction to settle any dispute which may arise out of, under, or in connection with these Terms or the legal relationship established by them, and for those purposes irrevocably submit all disputes to the jurisdiction of Singapore courts. For the exclusive benefit of Angeline Yong Dermatology and its affiliates, Angeline Yong Dermatology and its affiliates shall retain the right to bring proceedings as to the substance of the matter in the courts of the country of your residence or, where these Terms are entered into in the course of your trade or profession, the country of your principal place of business.

Media.

Donor Supply: The Real Limit On Any Hair Transplant